Advancing medical affair capabilities and insight generation through machine learning techniques.
Karen Ka Yan NgPeter Chengming ZhangPublished in: Journal of pharmaceutical policy and practice (2023)
There are numerous opportunities for innovation within the intersection of healthcare and data science. Pharmaceutical manufacturers, with one of their medical affairs responsibilities being the collection of unsolicited inquiries, particularly from HCPs, stand poised to leverage machine learning capabilities to optimize its processes. The abundance of data generated by the growing effort to use it in meaningful ways presents an opportunity for pharmaceutical companies to harness machine learning techniques.